Editors: " Prof. Dr. Atta-ur-Rahman", "Prof. Dr. M. Iqbal Choudhary"

Anti-Obesity Drug Discovery and Development

Volume 3

Personal Book: US $79 Special Offer (PDF + Printed Copy): US $158
Printed Copy: US $119
Library Book: US $316
ISSN: 2467-9615
eISSN: 2210-2698 (Online)
ISBN: 978-1-68108-188-5
eISBN: 978-1-68108-187-8 (Online)
DOI: 10.2174/97816810818781170301

Introduction

Obesity is a complex health problem, caused by a number of factors such as excessive food intake, lack of physical activity, genetic predisposition, endocrine disorders, medications and psychiatric illnesses. Onset of obesity in both the developing and the developed world has reached epidemic proportions. In response to this, efforts to control and treat obesity have also been vigorously pursued, ranging from raising awareness about lifestyle changes to the discovery and development of safe and effective anti-obesity drugs.

Anti-obesity Drug Discovery and Development is focused on this very important area of healthcare research. The third volume of this series is dedicated to anti-obesity treatments including updates on new therapeutics for obesity, Nesfatin-1 and its therapeutic uses, the role of proteomics in pediatric anti-obesity treatment, the role of oxidative stress in childhood obesity and a review of data on gut microbiota as a treatment option for obesity.

Indexed in: Scopus, Ulrich's Periodicals Directory.

Contributors

Editor(s):
Prof. Dr. Atta-ur-Rahman
Honorary Life Fellow
Kings College
University of Cambridge
Cambridge
UK


Prof. Dr. M. Iqbal Choudhary
H.E.J. Research Institute of Chemistry
International Center for Chemical and Biological Sciences
University of Karachi
Karachi
Pakistan




Contributor(s):
Antonio Mancini
Departments of Medical Sciences and Pediatrics
Catholic University of the Sacred Heart
Rome
Italy


Aurora Natalia Rossodivita
Departments of Medical Sciences and Pediatrics
Catholic University of the Sacred Heart
Rome
Italy


Amrit Lamba
Department of Internal Medicine
Tulane University
New Orleans
LA
USA


Chantal Di Segni
Departments of Medical Sciences and Pediatrics
Catholic University of the Sacred Heart
Rome
Italy


Carmine Finelli
Department of Emergency and Internal Medicine
S. Maria della Pietà Nola’s Hospital, Via della Repubblica 1
80035 Nola (Na)
Italy


Chihiro Okuma
Central Pharmaceutical Research Institute
Japan Tobacco Inc.
Takatsuki
569-1125 Osaka
Japan


David A. Johnson
Department of Internal Medicine
Division of Gastroenterology and Hepatology, Eastern Virginia Medical School
Norfolk
VA
USA


Edward C. Oldfield
Department of Internal Medicine
Eastern Virginia Medical School
Norfolk
VA
USA


Francesco Leo
Departments of Medical Sciences and Pediatrics
Catholic University of the Sacred Heart
Rome
Italy


Flavia Prodam
Division of Pediatrics, Department of Health Sciences
Università Del Piemonte Orientale
Novara
Italy


Gianni Bona
Division of Pediatrics, Department of Health Sciences
Università Del Piemonte Orientale
Novara
Italy


Gillian E. Walker
Laboratory of Clinical Pediatrics, Department of Health Sciences
Università del Piemonte Orientale
Via Solaroli
Novara
Italy


Marilisa De Feudis
Laboratory of Clinical Pediatrics, Department of Health Sciences
Università del Piemonte Orientale
Via Solaroli
Novara
Italy


Marta Roccio
Laboratory of Clinical Pediatrics, Department of Health Sciences
Università del Piemonte Orientale
Via Solaroli
Novara
Italy


Parth J. Parekh
Department of Internal Medicine, Division of Gastroenterology and Hepatology
Tulane University
New Orleans
LA
USA


Sebastiano Raimondo
Departments of Medical Sciences and Pediatrics
Catholic University of the Sacred Heart
Rome
Italy


Takeshi Ohta
Central Pharmaceutical Research Institute
Japan Tobacco Inc.
Takatsuki
569-1125 Osaka
Japan


Yukihito Ishii
Central Pharmaceutical Research Institute
Japan Tobacco Inc.
Takatsuki
569-1125 Osaka
Japan